Medicon Hellas S.A. (ATH:MEDIC)

Greece flag Greece · Delayed Price · Currency is EUR
2.860
-0.040 (-1.38%)
At close: Jun 26, 2026
Market Cap12.64M +22.7%
Revenue (ttm)17.95M -0.9%
Net Income1.73M +26.8%
EPS0.39 +26.8%
Shares Out 4.42M
PE Ratio7.30
Forward PEn/a
Dividend0.13 (4.55%)
Ex-Dividend DateJul 4, 2025
Volume620
Open2.770
Previous Close2.900
Day's Range2.770 - 2.860
52-Week Range2.210 - 2.970
Beta0.46
Analystsn/a
Price Targetn/a
Earnings DateSep 30, 2026

About Medicon Hellas

Medicon Hellas S.A. operates in the diagnostics industry that offers instruments, tests, and procedures to clinical and research labs in Greece and internationally. It manufactures, imports, and provides diagnostic and point-of-care test systems, molecular diagnostics, laboratory automation, work flow improvement, and software solutions and services to state and private hospitals and laboratories. The company also produces and exports clinical chemistry, hematology and immunochemistry reagents. In addition, it offers analyzers, reagents, contro... [Read more]

Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Founded 1988
Employees 148
Stock Exchange Athens Stock Exchange
Ticker Symbol MEDIC
Full Company Profile

Financial Performance

In 2025, Medicon Hellas's revenue was 17.95 million, a decrease of -0.94% compared to the previous year's 18.12 million. Earnings were 1.73 million, an increase of 26.81%.

Financial Statements